Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev®

NACompletedINTERVENTIONAL
Enrollment

244

Participants

Timeline

Start Date

May 5, 2022

Primary Completion Date

January 3, 2024

Study Completion Date

January 3, 2024

Conditions
Type 1 Diabetes
Interventions
DEVICE

MiniMed 780G System

MiniMed™ 780G Insulin Pump, Guardian™ 4 Glucose Sensor, and Guardian 4 Transmitter; used with Insulin Lyumjev® insulin lispro-aabc

Trial Locations (19)

21229

Barry J Reiner MD LLC, Baltimore

27834

Physicians East, Greenville

30076

Endocrine Research Solutions, Roswell

30318

Atlanta Diabetes, Atlanta

31210

East Coast Institute for Research - Macon, Macon

32204

East Coast Institute for Research (Memorial Hospital), Jacksonville

33612

University of South Florida Diabetes Center, Tampa

55416

International Diabetes Center, Saint Louis Park

55905

Mayo Clinic, Rochester

78229

Diabetes and Glandular Disease Clinic, P.A, San Antonio

78749

Texas Diabetes, Austin

80045

Barbara Davis Center for Childhood Diabetes, Aurora

Barbara Davis Center, Aurora

83404

Rocky Mountain, Idaho Falls

89113

The Docs LLC, Las Vegas

92123

Rady Children's Hospital San Diego, San Diego

94304

Stanford University, Palo Alto

98057

Rainier Research, Renton

06511

Yale University, New Haven

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Medtronic Diabetes

INDUSTRY